BioCentury
ARTICLE | Clinical News

Thrombus imaging agent containing a genetically engineered polypeptide

May 6, 1996 7:00 AM UTC

Bio-Technology General Corp. (BTGC), Iselin, N.J. Product: Thrombus imaging agent containing a genetically engineered polypeptide Use: Image and detect blood clots Status: BTGC licensee Merck Frosst ...